Novo Nordisk (spons. ADRs) Aktie
42,98
EUR
+0,62
EUR
+1,46
%
48,70
USD
-0,07
USD
-0,14
%
Novo Nordisk (spons. ADRs) jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Novo Nordisk (spons. ADRs) Aktie Analyse
| 30.05.12 | Novo Nordisk (spons. ADRs) underperform | Cheuvreux SA | |
| 22.03.12 | Novo Nordisk (spons. ADRs) sell | Deutsche Bank AG | |
| 22.03.12 | Novo Nordisk (spons. ADRs) reduce | Nomura | |
| 21.02.12 | Novo Nordisk (spons. ADRs) reduce | Nomura | |
| 30.01.12 | Novo Nordisk (spons. ADRs) reduce | Nomura | |
| 13.01.12 | Novo Nordisk (spons. ADRs) reduce | Nomura | |
| 09.11.11 | Novo Nordisk (spons. ADRs) reduce | Nomura | |
| 28.10.11 | Novo Nordisk (spons. ADRs) reduce | Nomura | |
|
Werbung
|
|||
| 28.09.05 | Novo Nordisk (spons. ADRs) Underweight | JP Morgan | |
Werbung
Werbung